• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
, a Forgotten Potential Therapy for Parkinson's Disease?,一种被遗忘的帕金森病潜在疗法?
Mov Disord Clin Pract. 2015 Oct 6;3(1):19-26. doi: 10.1002/mdc3.12242. eCollection 2016 Jan-Feb.
2
Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.Banisteriopsis caapi 的成分、标准化和化学成分分析,这种植物用于治疗与帕金森病相关的神经退行性疾病。
J Ethnopharmacol. 2010 Apr 21;128(3):662-71. doi: 10.1016/j.jep.2010.02.013. Epub 2010 Feb 26.
3
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease.卡瓦胡椒,一种独特的 MAO 抑制和抗氧化成分的组合,具有与神经退行性疾病和帕金森病相关的活性。
J Ethnopharmacol. 2010 Feb 3;127(2):357-67. doi: 10.1016/j.jep.2009.10.030. Epub 2009 Oct 30.
4
A rapid and simple method for the determination of psychoactive alkaloids by CE-UV: application to Peganum Harmala seed infusions.一种采用毛细管电泳-紫外检测法快速简便测定精神活性生物碱的方法:应用于骆驼蓬籽浸剂
Drug Test Anal. 2017 Apr;9(4):596-602. doi: 10.1002/dta.1989. Epub 2016 Jul 5.
5
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.卡皮木(Banisteriopsis caapi)对 MPTP 诱导的帕金森病恒河猴模型运动障碍的影响。
Phytother Res. 2018 Apr;32(4):678-687. doi: 10.1002/ptr.6017. Epub 2018 Jan 24.
6
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.卡皮木中的生物碱能刺激体外培养的成体神经发生。卡皮木是亚马逊致幻剂阿亚胡斯卡的植物来源。
Sci Rep. 2017 Jul 13;7(1):5309. doi: 10.1038/s41598-017-05407-9.
7
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.与帕金森病相关的卡皮藤提取物及其成分的活性。
Pharmacol Biochem Behav. 2003 Jun;75(3):627-33. doi: 10.1016/s0091-3057(03)00129-1.
8
Various alkaloid profiles in decoctions of Banisteriopsis caapi.卡皮藤煎剂中的各种生物碱谱。
J Psychoactive Drugs. 2005 Jun;37(2):151-5. doi: 10.1080/02791072.2005.10399796.
9
Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela.
J Psychoactive Drugs. 2008 Sep;40(3):301-7. doi: 10.1080/02791072.2008.10400645.
10
Biodiversity of β-Carboline Profile of and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential.植物“死藤水”及其具有神经药理学潜力的酿造物中β-咔啉成分的生物多样性。
Plants (Basel). 2020 Jul 9;9(7):870. doi: 10.3390/plants9070870.

引用本文的文献

1
Serotonin signaling to regulate energy metabolism: a gut microbiota perspective.从肠道微生物群角度看血清素信号传导对能量代谢的调节
Life Metab. 2024 Nov 23;4(2):loae039. doi: 10.1093/lifemeta/loae039. eCollection 2025 Apr.
2
A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers.一项在健康志愿者中进行的纯口服哈梅林单剂量递增的 1 期研究。
J Psychopharmacol. 2024 Oct;38(10):911-923. doi: 10.1177/02698811241273772. Epub 2024 Sep 20.
3
A Review of the Protective Effects of Alkaloids against Alpha-synuclein Toxicity in Parkinson's Disease.生物碱对帕金森病中α-突触核蛋白毒性的保护作用综述
Mini Rev Med Chem. 2025;25(2):112-127. doi: 10.2174/0113895575306884240604065754.
4
Preliminary evidence of links between ayahuasca use and the corpus callosum.使用死藤水与胼胝体之间联系的初步证据。
Front Psychiatry. 2022 Oct 26;13:1002455. doi: 10.3389/fpsyt.2022.1002455. eCollection 2022.
5
Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.含裸盖菇素的蘑菇:精神病学、生物医学和营养保健领域中一个快速发展的生物技术产业。
3 Biotech. 2022 Dec;12(12):339. doi: 10.1007/s13205-022-03355-4. Epub 2022 Nov 4.
6
Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.帕金森病调控子在黑质和前额皮质中的作用及其在药物重定位中的应用。
Mol Neurobiol. 2021 Apr;58(4):1517-1534. doi: 10.1007/s12035-020-02203-x. Epub 2020 Nov 19.
7
Identification of biosynthetic genes for the β-carboline alkaloid kitasetaline and production of the fluorinated derivatives by heterologous expression.鉴定β-咔啉生物碱基他沙林的生物合成基因,并通过异源表达生产其氟化衍生物。
J Ind Microbiol Biotechnol. 2019 May;46(5):739-750. doi: 10.1007/s10295-019-02151-z. Epub 2019 Feb 20.

本文引用的文献

1
Harmine treatment enhances short-term memory in old rats: Dissociation of cognition and the ability to perform the procedural requirements of maze testing.哈尔明治疗可增强老年大鼠的短期记忆:认知与执行迷宫测试程序要求能力的分离。
Physiol Behav. 2015 Jan;138:260-5. doi: 10.1016/j.physbeh.2014.09.001. Epub 2014 Sep 22.
2
Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.有证据表明,绕过首过代谢的选择性单胺氧化酶-B抑制剂司来吉兰制剂也能抑制人类大脑中的单胺氧化酶-A。
Neuropsychopharmacology. 2015 Feb;40(3):650-7. doi: 10.1038/npp.2014.214. Epub 2014 Sep 24.
3
Harmine mediated neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia.在全脑缺血大鼠模型中,通过评估谷氨酸转运体1探讨骆驼蓬碱介导的神经保护作用。
Neurosci Lett. 2014 Nov 7;583:32-6. doi: 10.1016/j.neulet.2014.09.023. Epub 2014 Sep 17.
4
DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.双特异性酪氨酸磷酸化调节激酶1A(DYRK1A)在发育中的大脑以及帕金森病小鼠模型中促进多巴胺能神经元的存活。
Cell Death Dis. 2014 Jun 12;5(6):e1289. doi: 10.1038/cddis.2014.253.
5
Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice.哈尔明碱和哈马灵可下调 C57BL/6 小鼠肝脏和肺部 TCDD 诱导的 Cyp1a1。
Biomed Res Int. 2013;2013:258095. doi: 10.1155/2013/258095. Epub 2012 Dec 20.
6
Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor.骆驼蓬碱震颤:特发性震颤潜在动物模型的潜在机制
Tremor Other Hyperkinet Mov (N Y). 2012;2. doi: 10.7916/D8TD9W2P. Epub 2012 Sep 12.
7
Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell.哈尔明增强伏隔核壳部电刺激诱发的多巴胺释放。
J Psychopharmacol. 2013 Jan;27(1):98-108. doi: 10.1177/0269881112463125. Epub 2012 Oct 17.
8
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.运动障碍学会循证医学综述更新:帕金森病运动症状的治疗方法。
Mov Disord. 2011 Oct;26 Suppl 3:S2-41. doi: 10.1002/mds.23829.
9
Activation, regulation, and inhibition of DYRK1A.DYRK1A 的激活、调节和抑制。
FEBS J. 2011 Jan;278(2):246-56. doi: 10.1111/j.1742-4658.2010.07956.x. Epub 2010 Dec 3.
10
Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus.慢性给予哈林可引起大鼠海马体产生抗抑郁样效应并增加脑源性神经营养因子水平。
J Neural Transm (Vienna). 2010 Oct;117(10):1131-7. doi: 10.1007/s00702-010-0451-2. Epub 2010 Aug 5.

,一种被遗忘的帕金森病潜在疗法?

, a Forgotten Potential Therapy for Parkinson's Disease?

作者信息

Djamshidian Atbin, Bernschneider-Reif Sabine, Poewe Werner, Lees Andrew J

机构信息

Department of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies University of London London United Kingdom.

Department of Neurology Medical University Innsbruck Innsbruck Austria.

出版信息

Mov Disord Clin Pract. 2015 Oct 6;3(1):19-26. doi: 10.1002/mdc3.12242. eCollection 2016 Jan-Feb.

DOI:10.1002/mdc3.12242
PMID:30713897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6353393/
Abstract

, a liana indigenous to the Amazon basin with metagnomigenic properties and possible anti-depressant effects is one of the natural sources of harmala alkaloids. A summary of early trials with extracts of and (from which harmine was first isolated) in the 1920s and 1930s on various forms of parkinsonism is given as well as a brief overview of the known pharmacological properties of harmine. Despite its earlier abandonment because of perceived weaker efficacy than solanaceous alkaloids like scopolamine and hyoscine we propose that harmine should be reconsidered as a potential rapidly acting anti-Parkinsonian agent.

摘要

一种原产于亚马逊盆地的藤本植物,具有致幻特性和可能的抗抑郁作用,是哈尔满生物碱的天然来源之一。文中给出了20世纪20年代和30年代对[植物名称1]和[植物名称2](从中首次分离出哈尔明)提取物针对各种帕金森病形式进行的早期试验总结,以及哈尔明已知药理特性的简要概述。尽管由于认为其疗效比东莨菪碱和海索比妥等茄科生物碱弱而较早被放弃,但我们认为哈尔明应被重新视为一种潜在的快速起效的抗帕金森病药物。